Revised advisory on the use of Hydroxychloroquine (HCQ) as prophylaxis for COVID-19 infection

Revised advisory on the use of Hydroxychloroquine (HCQ) as prophylaxis for COVID-19 infection (in supersession of previous advisory dated 23rd March, 2020) The National Task force (NTF) for COVID-19 constituted by Indian Council of Medical Research also reviewed the use of HCQ for prophylaxis of SARS-CoV-2 infection for high risk population based on the emerging evidence on its safety and efficacy.

(Edited)
Curofy Discussion attached PDF Gallery

19 Likes

LikeAnswersShare
NTF keeps on changing its guide lines on dosage schedule o Of HCQ for Covid-19. Nothing is on record about its benefits except shortening Of convalescence in some cases .Side effects are many and drug should be administered under medical supervision. Is it worth prescribing a drug which can have dreaded Side effects of heart blocks and cardiomyopathy?
What should be dose for different age. With the arrival of rains, malaria also will be seen. Will it protect both disease.
Thnks dr kiran mahajan
Nice informative post
Good information.
Informative post
Good news

Cases that would interest you